Report
100% drug tariffs could threaten smaller biotech firms
Axios reports that 100% tariffs pose a threat to small and midsize biotech firms that outsource their manufacturing.
TLDR
Axios says 100% drug tariffs could threaten small and midsize biotech firms that outsource their manufacturing.
Combined views
24.1K
2 Sources, first seen 7h ago
10 likes